Alignment Healthcare (ALHC) EBIT (2020 - 2026)

Alignment Healthcare (ALHC) has 7 years of EBIT data on file, last reported at $15.5 million in Q1 2026.

• For the quarter ending Q1 2026, EBIT rose 387.47% year-over-year to $15.5 million; the trailing twelve-month figure through Mar 2026 stood at $35.6 million (up 154.14% YoY), and the FY2025 full-year result was $14.8 million, up 114.53% from the prior year.
• EBIT for Q1 2026 stood at $15.5 million, up from -$10.3 million in the prior quarter.
• Across five years, EBIT topped out at $22.7 million in Q2 2025 and bottomed at -$52.1 million in Q4 2022.
• The 5-year median for EBIT is -$22.5 million (2024), against an average of -$19.3 million.
• The widest annual swing landed in 2023, when EBIT slumped 255.88%; it then soared 387.47% in 2026.
• A 5-year view of EBIT shows it stood at -$52.1 million in 2022, then grew by 19.56% to -$41.9 million in 2023, then soared by 46.21% to -$22.5 million in 2024, then soared by 54.38% to -$10.3 million in 2025, then soared by 250.75% to $15.5 million in 2026.
• The last three EBIT figures came in at $15.5 million (Q1 2026), -$10.3 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.

Peer Comparison